Stories & News

Shining a Light on Dr. Mipsang’s Dedication

Physicians are an essential part of our work. We partner with more than 500 healthcare professionals who provide cancer treatment in low- and middle-income countries. They volunteer to be in...

What I have learned in 33 years since losing Max

I have learned that the pain in the heart and soul is deep and will always be there. The ‘bucket’ has a hole, and even when you dedicate every day...

Shining a Light on Kiran’s Determination

Living with cancer can be overwhelming, to say the least. People with chronic myeloid leukemia (CML) have to take daily medication, travel to clinics, and carefully monitor their symptoms, on...

Am I Doing Enough?

Birthdays are a time to take stock on our life. This birthday, I feel unsettled, questioning if I am doing everything I can.

First Doses of BRUKINSA® provided to Patients with Chronic Lymphocytic Leukemia in Low- and Middle-Income Countries Under Collaboration of The Max Foundation, BeiGene, and the BeiGene Foundation

Armenia and Nepal are the first of 29 countries to receive BRUKINSA SEATTLE & BASEL & BEIJING & CAMBRIDGE, Mass. – March 13, 2024 — The Max Foundation (Max), a...

The Max Foundation Announces Agreement with Lilly to Provide Access to Verzenio® (abemaciclib) for the Treatment of Advanced Breast Cancer in Kenya

Agreement to provide Verzenio® (abemaciclib) free of charge to patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer (ABC) Lilly joins ongoing effort of...